Table 1 Main patients characteristics
Characteristics | Parameters | Values |
|---|---|---|
Age | Mean | 54.9 |
Median | 55 | |
Range | 30-74 | |
Karnofsky Performance Status | Median | 90 |
Range | 80–100 | |
Body Mass Index | Mean | 24.3 |
Median | 24 | |
Range | 20-32 | |
Breast Side | Right | 24 (58.5%) |
Left | 17 (41.5%) | |
Pathological Tumor Stage | Tis | 2 (4.9%) |
T1 | 29 (70.7%) | |
T2 | 10 (24.4%) | |
Pathological Nodal Stage | N0 | 28 (68.3%) |
N1 | 13 (31.7%) | |
Surgery | Conservative surgery + biopsy of sentinel node | 28 (68.3%) |
Conservative surgery + axillary node dissection | 13 (31.7%) | |
Histology | Ductal infiltring carcinoma | 31 (75.6%) |
Lobular infiltring carcinoma | 5 (12.2%) | |
Mixed carcinoma | 3 (7.3%) | |
In-situ ductal carcinoma | 2 (4.9%) | |
Estrogen/Progesteron Receptors | Positive | 27 (65.9%) |
Negative | 14 (34.1%) | |
Anti-Hormone Therapy | Yes | 19 (46.3%) |
No | 22 (53.7%) | |
Adjuvant Chemotherapy | Yes | 10 (24.4%) |
No | 31 (75.6%) | |
Optimal Position | Prone | 29 (70.7%) |
Supine | 12 (29.3%) |